MAKO (MAKO Surgical Corp)

Medical Instruments, Healthcare-Products, Consumer, Non-cyclical



Follow these portfolios. With IB Asset Management you can see every trade these investors make with their own money & automatically follow them in your own account.

Sign up now or Try IB Asset Management for free

Portfolios in the same sector - sorted by percentage allocation

The Freedland Healthcare portfolio invests in healthcare-related stocks. It attempts to identify companies with reasonable valuations and good prospects for growth including ones that offer possible dividends to stockholders. These companies will range from drug, device, retail sales, electronic medical record, prescription services, and HMO/hospital companies. While emphasizing mid cap stocks, large cap and smaller capitalization companies may be included as well as emerging medical treatments/technologies.

Companies selected for this portfolio are closely monitored. Stocks are typically acquired slowly. Freedland attempts to limit losses by selling losing positions quickly. In the same way, he will attempt to preserve capital by moving towards a cash position during weak market environments and towards equities during periods of market strength. The market environment will be assessed by observing the price behavior of the individual holdings within the portfolio itself.

Strategy
Stocks
Sharpe ratio
1.78 365 days
Performance
23.5% 365 days
Risk score
Fees
  • 1% fee
  • $20,000 min

We focus on US takeover targets or potential takeover targets and use screening guidelines including liquidity, premium and share price. Our focus is current US takeover targets or potential targets.

Strategy
Stocks
Sharpe ratio
-0.88 365 days
Performance
-8.0% 365 days
Risk score
Fees
  • 1% fee
  • $10,000 min

Our Small Cap portfolio seeks to achieve capital appreciation by primarily investing in small companies with above average growth potential.  Small companies, according to the manager, are companies whose market capitalizations are generally less than $2 billion at the time of purchase.  The manager maintains a concentrated portfolio of small cap companies traded on US exchanges.

Strategy
Stocks

This portfolio is new to IB Asset Management and does not have 365 days worth of daily performance data required for us to calculate risk metrics.

Sharpe ratio
-
Performance
Risk score
Fees
  • 1.25% fee
  • $35,000 min

The Sparrow Capital Fund is a long/short equity portfolio that invests across market sectors, industries, and market capitalization ranges. The Sparrow Capital Fund’s objective is to provide the most efficient risk/reward outcome over time. The strategy is intended to achieve market neutrality.

Strategy
Stocks
Sharpe ratio
0.41 365 days
Performance
5.2% 365 days
Risk score
Fees
  • 1.5%
  • 12% perf fee
  • $50,000 min

Vista Investment Management employs a Core Equity strategy. The primary objective is growth of capital with a moderate level of risk. The model portfolio is highly diversified and has exposure to virtually all major equity sectors.

Strategy
Stocks
Sharpe ratio
1.35 365 days
Performance
13.4% 365 days
Risk score
Fees
  • 0.5% fee
  • $20,000 min



Important Information

  1. Past performance is no guarantee of future results.
  2. Periodic and since and the corresponding spark chart is calculated to the most recent month end date.
  3. Benchmark returns have been calculated by IB Asset Management using a time-weighted calculation of daily index valuations.
  4. All graph data is as of the end of day for the referenced period, unless otherwise specified.